Six Years, One Substance, Two Columns: Reading Ruti Aga's Ban Through the Attempt Sheet

Six years. From the tenth of September. A sample collected after winning a half marathon in China in March. A knee injection on paper. A clinic that does not exist. A 'doctor' who was a family member with no medical registration, writing on an old prescription pad from a former workplace. The story looks clean. It is not.

If I settled one thing first in this case, it was that headlines would not come before facts. Forty years of habit: the result sheet and the attempt sheet go on the desk before the pen comes out. In Seoul 2026, when I was a 22-year-old junior copy assistant on a Delhi sports desk hand-timing every P.T. Usha final on a stopwatch, the order was the same. Two columns. One for what happened. One for what we wished had. The gap between them was the actual report.

What is in the first column this time? The Athletics Integrity Unit statement. Two years for presence. Four years for tampering. Six total, from 10 September, backdated to the provisional suspension. The March half marathon result and its prize money: not spelled out in the source, but automatic under standard AIU practice. What is in the second column? A story in which the word 'steroid' was written with great comfort, when the truth is that methylprednisolone is not an anabolic steroid but a glucocorticoid—class S9 on the WADA Prohibited List—and it is prohibited in-competition only, by injection, oral or rectal route. The same knee injection out of competition is entirely legal.

Stop here. I know a sub-editor's hand will tremble over this paragraph. But when a journalist writes 'steroid,' he plants an image of Lance Armstrong and Ben Johnson in the reader's mind. This case is not that kind. This case is about timing. About route. And, above all, about paperwork.

The whole case sits on one formula: two years presence + four years tampering. Anyone who reads that arithmetic sees one thing clearly—the panel did not accept the no-significant-fault relief on the presence charge. Had it, two years could have come down substantially. It did not. Why? Because the moment the athlete produced a forged prescription, she destroyed the strongest defence available to her.

I remember Anju's attempt sheet. Paris 2026, World Championships, bronze, 6.70m. I was 39 and on the athletics beat for the first time. The tribune was writing 'first Indian medal,' and I was at the IAAF media desk asking for all six attempts. Her five legal marks sat inside a 22-centimetre band—the tightest series in the top eight, from an athlete with one kidney. I filed 900 words saying the bronze was won on consistency, not one lucky jump. Anju wrote down every attempt, including the embarrassing ones. That is the difference. An athlete who records her real paperwork does not commission a fake prescription.

Now look at the medical side, because the root is there. Knee synovitis and swelling are routine in marathoners; the knee is the joint that fails first under high mileage. Intra-articular methylprednisolone is standard treatment. That plausibility explains what stings most: if the treatment had been real, real records would have defended it. When you have the truth, you do not forge the paper.

One more fact before the medical road. The March race in China: no time is given in the source. No splits, no field depth. Any performance comment here would be invention, and I will not write it. Yes, one thing I can say—she won, so the field had World Athletics Label-tier organisation and in-competition testing. That is all.

Here the hinge begins. A road race's testing window opens at 23:59 the day before the race. An injection given two or three days earlier leaves residues caught in competition. This is not a 'took steroids' story. It is a 'did not calculate clearance' story. And the striking part: that clearance-timing responsibility arrives when you have a team physician. The clear signal here is that she did not.

That 'doctor' was a family member with no medical registration, who named a clinic that does not exist, who claimed an 'old pad from a former workplace' that the clinic explicitly disowned. Three independent verification failures on one slip. This is not a filing error. It is the failure of the medical governance that elite road running does not have.

Now the second column, which wants writing. In the road-racing camps of Ethiopia and Kenya an informal crew orbits the athlete—a gardener, a masseur, someone who can give an injection, and a relative everyone calls 'Doctor.' A marathoner's career runs in the 2:18–2:20 range, and her income comes from appearance fees and prize money. An aching knee means missing a race means missing money. A glucocorticoid is the cheapest, most available tool for hiding pain. That is a systemic gap more than a character flaw. But—and here I rein myself in—the indictment does not go to administration. The AIU statement names no agent or management investigation. The name given was a family member. What was done, the athlete did.

There is another point that makes the arithmetic interesting. Six years for a glucocorticoid. This is the substance with no proven endurance benefit. This is not the substance whose credit a victory takes. So the penalty is not for the substance—it is for the paper. The substance is two years; the paper is four. That is the single biggest lesson of the case: in the modern anti-doping system, the greater offence is trying to hide it.

The hardest part of AIU's work is becoming document verification. When East African road-racing cases arrive, they arrive with a fabricated explanation laid over the initial violation. Aga's case is the clearest example of that family, not an outlier. Where a slip was made once, it can be made again.

Now the third column—unpublished, but kept in the arithmetic. What improved here? If WADA had not clarified in 2026 that S9 applies only in competition, the shape of this case would be different. The rule changed, so the athlete's defence route changed. That does not mean she used it—she chose the forged route instead. But as a reporter I note that clarity in the rules was real, countable progress.

Then age. Thirty-two. Thirty-eight after six years. Ethiopia's women's marathon depth is such that a 2:18-class runner cannot lock a national-team place. A 38-year-old returning with a doping record is, in selection terms, close to zero. So this is not a six-year ban. It is a career-lifetime ban for elite purposes. And a chemical did not build it. The athlete did.

Now the most cutting part. What does 'ban' mean in athletics? Not a release from a club. In athletics, the federation selects you, the railway posts you, the PSU or Services employs you. No transfer window, no franchise contract, no auction. So when we talk about an Ethiopian athlete's career, we are not talking about a pro-lucrative career. We are talking about an economy where crossing continents for appearance fees and prize money funds a household. Through that lens, six years is not only a ban on sport; it is a ban on a household budget. And that is why the mind builds toward hiding a knee ache.

My old habit—ask every mark for its conditions. So I ask here. The 'won' half marathon carries no time in the source. No wind reading, no rival. I will not say from that win that she was in brilliant form. I will only say that against paperwork, form becomes irrelevant. From Seoul 2026 to now I have held one principle: the Seiko never lied to me in 214 splits, so I tried never to lie to it. But the Seiko never explained why a runner finished fourth—I had to ask the track conditions and the race tempo. Same here. The clock does not tell this case 'why.' The clock tells only the time—six years.

The violation is proven; the sanction is imposed. Now a necessary comment tied to a bigger risk. Is six years disproportionate for a glucocorticoid? Separate two things. Two years for the substance. Four for the paper. Both are standard under the Code. And it is also true that the tampering penalty is severe because the system must keep its trust in the truth. But it is a fact too that in AIU's East African road-racing cases, tampering is not only a penalty statistic—it is the architecture of charging power. For an athlete without the resources of English or legal training, what she says in an investigative interview—the duty to record that neutrally belongs to the investigating agency. This is not an allegation, only the question I ask in every case: was there an inquiry that separated error from intent? The statement does not say. Nor does it say on what date the CAS appeal window (typically about 21 days) opened and closed.

One thing is clear to me here and one is hazy. Clear is what the AIU had as documents—the slip, the clinic's denial, the statement. Hazy is what mattered most: what the real medical process was. We do not know when Aga first treated the knee, whom she saw, and how many years the habit ran. But I can infer: the one who skips the formal route learns its value when the AIU letter arrives. By then it is too late.

Next time an athlete stands at the line with a knee ache—and there will be a next time, because knees ache every season in the marathon—one question should be asked first. Is the route real, or is it being built? Because on the fake route hangs a six-year signboard, and on the real route sit a TUE application, a correct clearance calculation and a regular physician's advice. The cost difference between the two routes is far smaller than six years.

My last word is not about this case's protagonist but its record. The 2026 Tokyo Marathon title, three World Marathon Majors second places—what exists there is not erased by a forged slip, unless the AIU counts it among sanctioned results. The source does not mention that boundary. So my question stays open: in the coming weeks, will the AIU clarify the effect on every result before and after 2026? And when it does, will we print it in the same place the six-year ban was printed—or only read the first corner?